SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-151950
Filing Date
2017-05-01
Accepted
2017-05-01 16:32:03
Documents
6
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A d347092ddefa14a.htm DEFA14A 51999
2 GRAPHIC g347092dsp044.jpg GRAPHIC 10208
3 GRAPHIC g347092dsp045a.jpg GRAPHIC 13678
4 GRAPHIC g347092dsp045b.jpg GRAPHIC 10086
5 GRAPHIC g347092dsp046.jpg GRAPHIC 10227
6 GRAPHIC g347092dsp047.jpg GRAPHIC 10248
  Complete submission text file 0001193125-17-151950.txt   128225
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37465 | Film No.: 17801208
SIC: 2834 Pharmaceutical Preparations